ZEVRA THERAPEUTICS, INC. — Director's Dealing 2016

Mar 30, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: KEMPHARM, INC (KMPH)
CIK: 0001434647
Period of Report: 2016-03-29

Reporting Person: Mickle Travis C (Director, President & CEO, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-03-29	Common Stock	P	2050	$14.5899	Acquired	2050	Indirect
2016-03-29	Common Stock	P	400	$14.485	Acquired	33614	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1381176	Direct
Common Stock	157197	Indirect
Common Stock	243880	Indirect
Common Stock	100604	Direct
Common Stock	230812	Indirect
Common Stock	230812	Indirect

Footnotes

F1: The Reporting Person and his spouse are the managing members of Mickle Investments LLC.

F2: Held jointly with spouse.